Bio Financial Statements From 2010 to 2024
| T1CH34 Stock | 13.44 1.06 7.31% |
Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as , as well as many indicators such as . Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.
Bio |
Bio Techne Company Return On Equity Analysis
Bio Techne's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Bio Techne Return On Equity | 0.15 |
Most of Bio Techne's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Techne is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Bio Techne has a Return On Equity of 0.1483. This is 100.62% lower than that of the Healthcare sector and 100.41% lower than that of the Biotechnology industry. The return on equity for all Brazil stocks is 147.84% lower than that of the firm.
Bio Techne Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bio Techne's current stock value. Our valuation model uses many indicators to compare Bio Techne value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio Techne competition to find correlations between indicators driving Bio Techne's intrinsic value. More Info.Bio Techne is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bio Techne is roughly 1.92 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bio Techne by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bio Techne's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Bio Techne Financial Statements
Bio Techne stakeholders use historical fundamental indicators, such as Bio Techne's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bio Techne investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bio Techne's assets and liabilities are reflected in the revenues and expenses on Bio Techne's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bio Techne. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Bio Stock
Bio Techne financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Techne security.